Thyroid Function Abnormalities in Women with Polycystic Ovary Syndrome (PCOS)A Clinical Study

Thyroid Function Abnormalities in Women with PCOS

Authors

  • Amna Akram Assistant Professor, Department of Biochemistry, Sahara Medical College Narowal, Pakistan Author
  • Awais Anwar Professor, Department of Physiology, Sahara Medical College Narowal, Pakistan Author
  • Razia Batool Department of Forensic Medicine, Sahara Medical College Narowal, Pakistan Author
  • Nosheen Sikandar Baloch Associate Professor, Department of Obstetrics and Gynaecology, Bolan Medical College, Quetta, Pakistan Author

DOI:

https://doi.org/10.69750/dmls.02.011.0173

Keywords:

Polycystic ovary syndrome, hypothyroidism, subclinical hypothyroidism, anti-TPO antibodies, insulin resistance, menstrual irregularities

Abstract

Background: Polycystic ovary syndrome (PCOS) is an endocrine disorder that occurs frequently in women of reproductive age, and it affects reproductive and metabolic activity. There is emerging evidences that indicate that there is a close relationship between PCOS and thyroid dysfunction. The study estimates the incidence of thyroid aberrations among women with PCOS and how these aberrations relate to reproductive and metabolic disorders.

Methods: A cohort study was used to assess 100 women aged 20-35 years with PCOS through the Rotterdam 2003 criteria. There were elaborate clinical histories, physical examination, and biochemical tests. A thyroid profile was performed to assess TSH, FT4, FT3, and anti-TPO antibodies. Other assessments were fasting insulin, HOMA-IR, lipids, and total testosterone. The participants were divided into two groups, namely normal thyroid functioning and thyroid dysfunction. Statistical analysis was done with SPSS version 26, with p < 0.05 as the significance level.

Results: Thyroid malfunction existed in 38 percent of PCOS women. The most frequent abnormality was subclinical hypothyroidism (26%), overt hypothyroidism (8%), and autoimmune thyroiditis (4%). Women who had a thyroid dysfunction had very high TSH levels and low FT4 levels. Menstrual problems were more common in the thyroid-abnormal group (84% vs. 61%), and infertility complaints were also more common (42% vs. 23%). Among the metabolic abnormalities, such as high fasting insulin, high HOMA-IR, high LDL, and low HDL, were much more common in women with thyroid dysfunction.

Conclusion: Thyroid dysfunction is very high among women with PCOS and leads to more severe reproductive and metabolic abnormalities. Thyroid screening must be regarded as a part and parcel of PCOS examination to enhance early disease identification, its management, and subsequent health outcomes.

Downloads

Download data is not yet available.

References

Fan H, Ren Q, Sheng Z, Deng G, Li L. The role of the thyroid in polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023;14:1242050. doi:10.3389/fendo.2023.1242050.

Yin D, Ruan X, Tian X, Du J, Zhao Y, Cui Y, et al. Relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome. Gynecol Endocrinol. 2017;33(4):332–335. doi:10.1080/09513590.2016.1273895.

Dsouza S, Hegde N. A study of thyroid function in polycystic ovary syndrome. Muller J Med Sci Res. 2023;14(1):55–58. doi:10.4103/mjmsr.mjmsr_63_22.

Palomba S, Colombo C, Busnelli A, Caserta D, Vitale G. Polycystic ovary syndrome and thyroid disorder: a comprehensive narrative review of the literature. Front Endocrinol (Lausanne). 2023;14:1251866. doi:10.3389/fendo.2023.1251866.

Trouva A, Alvarsson M, Calissendorff J, Åsvold BO, Vanky E, Hirschberg AL. Thyroid status during pregnancy in women with polycystic ovary syndrome and the effect of metformin. Front Endocrinol (Lausanne). 2022;13:772801. doi:10.3389/fendo.2022.772801.

Zhao Z, Gao Y, Pei X, Wang W, Wang R, Zhang H. Thyroid function and polycystic ovary syndrome: a Mendelian randomization study. Front Endocrinol (Lausanne). 2024;15:1364157. doi:10.3389/fendo.2024.1364157.

Zhao H, Zhang Y, Ye J, Wei H, Huang Z, Ning X, et al. Comparative study on insulin secretion, insulin resistance and thyroid function in patients with polycystic ovary syndrome with and without Hashimoto’s thyroiditis. Diabetes Metab Syndr Obes. 2021;14:1817–1821. doi:10.2147/DMSO.S300015.

van der Ham K, Stekelenburg KJ, Louwers YV, van Dorp W, Schreurs MWJ, van der Wal R, et al. Prevalence of thyroid dysfunction and hyperprolactinemia in women with PCOS. Front Endocrinol (Lausanne). 2023;14:1245106. doi:10.3389/fendo.2023.1245106.

Mukherjee P, Sanyal S, Chadha S, Mukherjee S. Impact of polycystic ovary syndrome on the risk of developing ovarian cancer and thyroid disorders: a comprehensive review. Endocr Metab Immune Disord Drug Targets. 2024;24(5):562–572. doi:10.2174/0118715303266512231103075551.

Hao X, Liu S, Zheng H, Wang Q, Jin L, Ma J. Thyroid hormones correlate to the therapeutic effect of ovulation induction in infertile women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2025;0:1–8. doi:10.1111/cen.70030.

Feigl S, Obermayer-Pietsch B, Klaritsch P, Pregartner G, Herzog SA, Lerchbaum E, et al. Impact of thyroid function on pregnancy and neonatal outcome in women with and without PCOS. Biomedicines. 2022;10:750. doi:10.3390/biomedicines10040750.

Kim JJ, Yoon JW, Kim MJ, Kim SM, Hwang KR, Choi YM. Thyroid autoimmunity markers in women with polycystic ovary syndrome and controls. Hum Fertil (Camb). 2020;25(1):128–134. doi:10.1080/14647273.2019.1709668.

Shi D, Du J, Kang H, Feng L, Liu F. Effect of subclinical hypothyroidism on hormonal and metabolic profiles and ovarian morphology in patients with polycystic ovary syndrome: a cross-sectional study. Gynecol Endocrinol. 2024;40(1). doi:10.1080/09513590.2024.2358219.

Abdul-ameer F, AlAsadi IJA, Hosseini A, et al. Relationship between serum CTRP-5, C3a/desArg, and complement C3 levels and hypothyroidism in women with polycystic ovary syndrome. BMC Endocr Disord. 2024;24:272. doi:10.1186/s12902-024-01801-3.

Hao X, Ma J, Zhang L, Meng T, Ma Q. Relationship between thyroid hormones and insulin resistance in polycystic ovary syndrome women. Gynecol Obstet Invest. 2024;89(6):512–519. doi:10.1159/000539361.

Ach T, Dhaffar R, Ben Abdessalem F, et al. Subclinical hypothyroidism in polycystic ovary syndrome: prevalence and impact on metabolic and cardiovascular risk. Clin Med Insights Endocrinol Diabetes. 2025;18:11795514251343678. doi:10.1177/11795514251343678.

Rasoulizadeh Z, Eftekhar M, Ghadiri-Anari A, et al. Prevalence of anti-thyroid peroxidase antibodies among women with polycystic ovary syndrome. Sci Rep. 2025;15:33563. doi:10.1038/s41598-025-18582-x.

Szydłowska I, Nawrocka-Rutkowska J, Gorzko A, Pawłowski H, Starczewski A, Szczuko M. Changes in hormonal profile and BMI in women with polycystic ovary syndrome after probiotic intake: a 12-week placebo-controlled randomized clinical study. Nutrients. 2025;17:405. doi:10.3390/nu17030405.

Dai F, Wu Z, Qin S, Wu F, Wang M, Liu X, Liu F. Influence of subclinical hypothyroidism on endocrine and metabolic characteristics in patients with polycystic ovary syndrome. Int J Womens Health. 2025;17:1019–1026. doi:10.2147/IJWH.S517997.

Nazarpour S, Mousavi M, Ramezani Tehrani F. Polycystic ovary morphology, subclinical hypothyroidism, and the cutoff value of thyroid-stimulating hormone: a population-based study. Reprod Sci. 2024;31:3899–3907. doi:10.1007/s43032-024-01741-2.

Downloads

Crossmark - Check for Updates PlumX Metrics

Published

30-11-2025

How to Cite

Akram, A., Anwar, A., Batool, R., & Baloch , N. S. (2025). Thyroid Function Abnormalities in Women with Polycystic Ovary Syndrome (PCOS)A Clinical Study: Thyroid Function Abnormalities in Women with PCOS. DEVELOPMENTAL MEDICO-LIFE-SCIENCES, 2(11), 18-22. https://doi.org/10.69750/dmls.02.011.0173

Share